Trade Summary

2 days ago, Mesa Nilda, serving as Dir at United Therapeutics Corp (UTHR), sold 258 shares at $581.94 per share, for a total transaction value of $150,139.00. Following this transaction, Mesa Nilda now holds 5,028 shares of UTHR.

This sale represents a 5.00% decrease in Mesa Nilda's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 1 day after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.